Catalyst Wire Dossier Catalyst Wire Dossier

ChampioNIR Drug Eluting Peripheral Stent

· Medinol Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ChampioNIR Drug Eluting Peripheral Stent, covering 2025-09-22 to 2025-09-22. Get the full timeline:

Most recent: Clinical Trial Update: First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease [NA]

See pricing